This website uses cookies to enhance the user experience.
||
RESMED NORWAY AS

RESMED NORWAY AS966 820 896

Purchase and sale
Limited company
Strandveien 17 1366 LYSAKER, Norge

RESMED NORWAY AS

Operating
Søvnapné og behandling av respirasjonslidelser | ResMed Norge
ResMeds tilkoblede løsninger forbedrer livet til millioner av mennesker med søvnapné og andre respirasjonslidelser - oppdag hva de kan gjøre for deg.
Salg av varer og tjenester, til offentlige og private virksomheter innenfor helsesektoren, samt hva dermed står i forbindelse herunder å delta i andre virksomheter.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

Chairman of the board
Years since formation
31 years
since Mar 12, 1995
Type
Limited company
VAT registered
Yes
Number of employees
10

Ownership

Number of shares and share classes
2,000,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
176,868,248
NOK
Annual total result 2025
6,534,715
NOK
Total equity 2025
32,286,045
NOK
Last update: Jan 14, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-

Others

NameRoleShares
Auditor-
Last update: Nov 10, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
2,000,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
176,868,248
168,672,539
157,514,761
142,943,777
Annual Total Result
6,534,715
5,863,856
5,406,746
4,925,979
Total assets
64,044,437
58,906,298
64,803,667
70,338,673
Total liabilities
31,758,393
33,154,969
44,916,194
55,857,947
Total equity
32,286,045
25,751,329
19,887,473
14,480,726

P&L

Year2024202320222021
Total operating income
176,868,248
168,672,539
157,514,761
142,943,777
Total operating costs
168,906,893
160,865,865
150,410,945
136,164,053
Operating result
7,961,355
7,806,675
7,103,816
6,779,724
Financial income/costs
419,574
-253,899
-170,801
-445,614
Profit before tax
8,380,928
7,552,775
6,933,015
6,334,110
Total tax & extraordinary income/cost
1,846,213
1,688,919
1,526,269
1,408,131
Annual Total Result
6,534,715
5,863,856
5,406,746
4,925,979

Balance overview

Year2024202320222021
Total fixed assets
1,574,885
2,206,469
2,768,715
2,023,133
Total current assets
62,469,552
56,699,829
62,034,951
68,315,540
Total assets
64,044,437
58,906,298
64,803,667
70,338,673
Short term debt
31,758,393
33,154,969
44,916,194
55,857,947
Long term debt
0
0
0
0
Total liabilities
31,758,393
33,154,969
44,916,194
55,857,947
Contributed capital
9,554,008
9,554,008
9,554,008
9,554,008
Retained earnings
22,732,037
16,197,321
10,333,465
4,926,718
Total equity
32,286,045
25,751,329
19,887,473
14,480,726
Total equity and liabilities
64,044,437
58,906,298
64,803,667
70,338,673

Classification

21st company classification
BETA
Industrial large enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods